Fjölmiðlaumfjöllun
1
Fjölmiðlaumfjöllun
Titill Amgen invests $66M in genetic sequencing company Oxford Nanopore Heiti/miðill fjölmiðla BioPharma Dive Land/Yfirráðasvæði Bandaríkin Dagsetning 19/10/18 URL https://www.biopharmadive.com/news/amgen-invests-66m-in-genetic-sequencing-company-oxford-nanopore/540100/ Aðilar Kári Stefánsson